ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q2 2019 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q2 2019 Earnings Conference Call
August 01, 2019, 04:30 PM ET
Company Participants
Felicia Vonella - Executive Director, IR
Ron Cohen - CEO
Lauren Sabella - CCO
David Lawrence - CTO, Chief of Business Operations & Principal Accounting Officer
Conference Call Participants
Paul Matteis - Stifel
Salveen Richter - Goldman Sachs
Phil Nadeau - Cowen and Company
Michael Yee - Jefferies
Charles Duncan - Cantor Fitzgerald
Edward Marks - HC Wainwright
Presentation
Operator
Welcome to the Acorda Therapeutics' Second Quarter 2019 Update. At this time, all participants are in a listen-only